Stay updated on ARO-APOC3 in FCS Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in FCS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No significant changes to the study details, eligibility criteria, outcomes, or recruitment status are evident between the screenshots. Any observed differences appear to be formatting or styling adjustments only.
    Difference
    0.3%
    Check dated 2025-11-03T01:20:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Version update from v3.1.0 to v3.2.0 with new funding/status notices and a new genetic disorder topic.
    Difference
    4%
    Check dated 2025-10-05T10:23:59.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.
    Difference
    0.6%
    Check dated 2025-09-28T03:18:00.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page updates from Revision: v3.0.1 to v3.0.2, signaling a minor update; the 'Back to Top' link was removed, a small navigational change with no evident impact on core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:37:15.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:22:09.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional publications related to drug safety and specific medical conditions. Notably, the drug 'plozasiran' is highlighted, indicating a focus on its management of certain diseases.
    Difference
    18%
    Check dated 2025-08-30T12:05:31.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.